The FDA approved darolutamide for mHSPC on June 3, [2025], so we now have this in our armamentarium, along with all the other ...
Background: Failure to detect significant drug interactions may result in adverse outcomes. While proper screening and management of drug interactions can prevent the majority of adverse events, ...
Pathway today announced the launch of a fully integrated drug reference and drug-drug interaction checker within its AI-powered medical knowledge platform. Clinicians can now access comprehensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback